Are mitochondria the instigator of pulmonary arterial hypertension?

12 June 2024

A PVRI 2024 Digital Webinar

12 June 2024, 3PM BST 

Presentations: 

  • Therapeutic efficacy and mechanisms of Drpitor1a in pulmonary arterial hypertension, Stephen Archer, Queens University, Canada
  • SNPs for sirtuin3 and uncoupling protein2 are causal of pulmonary arterial hypertension and diabetes disease severity, Evangelos Michelakis, University of Alberta, Canada
  • Mitochondrial control of metabolic, angiogenic, and hematopoietic function in pulmonary hypertension onset and progression, Olga Rafikova, Indiana University, USA
  • Heteroplasmy of wild-type mitochondrial DNA variants causes metabolic heart disease with pulmonary hypertension, Ana Victoria Lechuga, IRB Barcelona, Spain

Moderated by Bradley Wertheim, Mass General Brigham, USA and John Ryan, University of Utah, USA

Speakers & Moderators

Stephen Archer, Queens University, Canada
Evangelos Michelakis, University of Alberta, Canada
Olga Rafikova, Indiana University, USA
Ana Victoria Lechuga, IRB Barcelona, Spain
Bradley Wertheim, Mass General Brigham, USA
John Ryan, University of Utah, USA
Additional comments are available to members. Login or register to become a member today
Share: